The presence of a significant MI in a patient undergoing aortic valve replacement raises the problem of simultaneous correction of the two pathologies, which means an increase in operative mortality: on average 2.7% for single AVR and 6.5% for double replacement [5]. It is important to define the mechanism and severity of MI as accurately as possible in order to make an optimal surgical decision [1,3,4].
- Severe MI: a regurgitant orifice > 0.4 cm2 and a vena contracta > 0.7 cm in structural MI (> 0.3 cm2 and > 0.4 cm in ischaemic MI) are the most relevant indices. Colour jet size, PISA and regurgitation fraction are too dependent on haemodynamic conditions (increased LV afterload due to aortic stenosis). The presence of a severe MI is generally accepted as an indication for simultaneous replacement (MVR) or plasty (MVP), as it triples the mortality of AVR and the risk of cardiogenic shock during perioperative haemodynamic changes. On the other hand, there is virtually no likelihood of subsequent regression [6].
- Moderate to severe MI (regurgitant orifice 0.2-0.4 cm2 and vena contracta 0.3-0.6 cm): This doubles the operative mortality of AVR. If it is structural, there is a tendency to treat it at the same time if the operative risk is low or moderate (probable mortality of the combined operation < 5%) [4].
- Functional MI: With reduction of intraventricular pressure, it regresses after AVR in half of the cases, but does not improve in the long term in the other half [7].
- Factors favouring regression of MI after AVR: functional MI due to LV dysfunction, high preoperative aortic transvalvular pressure gradient.
- Factors associated with non-regression of MI after AVR: degenerative or rheumatic MI, mitral annular calcification, LA dilatation, chronic AF, pulmonary hypertension.
In patients at low or intermediate surgical risk with moderate-to-severe MI with a low probability of regression after AVR (structural MI), the surgical risk of double replacement is justified. If the surgical risk is high or the probability of regression of the MI is high (functional MI), single AVR is preferred [3].
The ideal conditions for each of the two pathologies appear to be contradictory; in fact, SAR should be high due to aortic stenosis to ensure coronary perfusion and low to limit MI. In reality, the increase in afterload is much more related to the aortic stenosis, which is fixed, than to SAR which is distal to the aortic valve. SAR can therefore be maintained with a vasopressor according to myocardial perfusion requirements without significantly affecting MI.
Hemodynamics in aortic stenosis and mitral insufficiency |
Aortic stenosis is the most dangerous component. High preload Normal to low rate Contractility preserved (inotropic support required) SAR preserved (diastolic blood pressure) Low PAR |
References
- BONOW RO, BROWN AS, GILLAM LD, et al. ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS/ 2017 appropriate use criteria for the treatment of patients with severe aortic stenosis. J Am Coll Cardiol 2017; 70:2566-98
- IUNG B, BARON G, BUTCHART EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24:1231-43
- NOMBELA-FRANCO L, BARBOSA RIBEIRO H, URENA M, et al. Significant mitral regurgitation left untreated at the time of aortic valve replacement. J Am Coll Cardiol 2014; 63:2643-58
- RAMAKRISHNA H, KOHL BA, JASSAR AS; et al. Incidental moderate mitral regurgitation in patients undergoing aortic valve replacement for aortic stenosis: review of Guidelines and current evidence. J Cardiothorac Vasc Anesth 2014; 28:417-22
- STS – Society of Thoracic Surgeons National Cardiac Surgery Database, 2017. https://www.sts.org/site/defaut/files/documents/ ACSD_ExecutiveSummary2017Harvest4_RevisedReport.pdf
- UNGER P, CLAVEL MA, LINDMAN BR, et al. Pathophysiology and management of multivalvular disease. Nat Rev Cardiol 2016; 13:429-40
- VAN DEN EYDEN F, BOUCHARD D, EL-HAMAMSY I, et al. Effect of aortic valve replacement for aortic stenosis on severity of mitral regurgitation. Ann Thorac Surg 2007; 83:1279-84